This was accomplished by evaluation of the levels of the markers of dyslipidaemia, oxidative stress and inflammation; namely, apolipoprotein B (Apo B), NO and ferritin, respectively, in the study group. This evidence concerns the gene APOB and inherited lipid metabolism disorder.